Finally, we confirmed high positivity of EV-SF3B4 in patients with overall negative AFP in HCC at 82% (Fig. 4D, left), in mUICC I/II at 83% (Fig. 4D, middle), and in mUICC I at 84% (Fig. 4D, right). This evidence concerns the gene SF3B4 and hepatocellular carcinoma.